NCT03001453View on ClinicalTrials.gov

Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Pain, Postoperative
Interventions
DRUG

Liposomal Bupivacaine

266mg liposomal bupivacaine

DRUG

0.25% Bupivacaine with epinephrine

0.25% bupivacaine with epinephrine

DRUG

Saline

Normal saline

Trial Locations (2)

60521

Adventist Hinsdale Hospital, Hinsdale

60559

American Hip Institute, Westmont

Sponsors
All Listed Sponsors
lead

American Hip Institute

OTHER